Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Australia Gets Tough on Orphan Drug Makers: Delay Filing and Designation Will Lapse

Executive Summary

Australia is updating its nearly two decades-old orphan drugs program. Sponsors who fail to file for approval within a set period will see their designation disappear.


Related Content

Australia Plans New Approval Pathways To Foster Earlier Access To Novel Drugs